Duloxetine (Yentreve®), behandeling stress-urine-incontinentie


1. NHG-Standaard Incontinentie voor urine via: Artsennet.
2. Stressincontinentie bij de vrouw. Behandelrichtlijnen SUI. Utrecht: Nederlandse Vereniging voor Urologie, 2003.
3. Dmochowski RR, et al. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. J Urol 2003; 170: 1259-1263.
4. Productinformatie duloxetine (Yentreve®) via: www.ema.europa.eu, human medicines, EPARs.
5. Norton PA, et al. Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol 2002; 187: 40-48.
6. Kerrebroeck P van, et al. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence. BJOG 2004; 111: 249-257.
7. Millard RJ, et al. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized trial. BJU Int 2004; 93: 311-318.
8. Cardozo L, et al. Pharmacological treatment of women awaiting surgery for stress urinary incontinence. Obstet Gynecol 2004; 104: 511-519.     

Auteurs

  • dr J.J. Beckeringh